ZYFLO
NDC 10122-901, zileuton, tablet, from Chiesi USA, Inc..
- Product NDC
- 10122-901
- Status
- Listed
- Labeler
- Chiesi USA, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020471
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10122-901 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZILEUTON600 mg/1
Pharmacologic classes
5-Lipoxygenase Inhibitor [EPC]; 5-Lipoxygenase Inhibitors [MoA]; Decreased Leukotriene Production [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10122-901-12 | 10122090112 | 120 TABLET in 1 BOTTLE (10122-901-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/aee65202-fddb-497f-9f11-17cc727cb157
Use it
Look up 10122-901 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10122-901 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10122-901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.